Evidence map›Paper›PMID 31416836›Full record

ArticleThe Journal of biological chemistry2019

Ega3 from the fungal pathogen

Natalie C Bamford, François Le Mauff, Adithya S Subramanian, Patrick Yip, Claudia Millán, Yongzhen Zhang, Caitlin Zacharias, Adam Forman, Mark Nitz, Jeroen D C Codée and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Characterization of theMicroorganisms · 2024
    Article
  11. Article
  12. UnderstandingCell surface (Amsterdam, Netherlands) · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Identification of Compounds PreventingInternational journal of molecular sciences · 2023
    Article
  18. The Bovhyaluronidase Azoximer (LongidazaMedicina (Kaunas, Lithuania) · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Natalie C BamfordProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.ORCID 0000-0003-1959-856X
François Le MauffDepartment of Microbiology and Immunology, Faculty of Medicine, McGill University, Montreal, Quebec H3A 2B4, Canada.
Adithya S SubramanianProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Patrick YipProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada.
Claudia MillánStructural Biology, Instituto de Biología Molecular de Barcelona, CSIC, Carrer Baldiri Reixac 15, 3 A17, Barcelona 08028, Spain.ORCID 0000-0002-9283-2220
Yongzhen ZhangLeiden Institute of Chemistry, Leiden University, 2300RA Leiden, The Netherlands.
Caitlin ZachariasDepartment of Microbiology and Immunology, Faculty of Medicine, McGill University, Montreal, Quebec H3A 2B4, Canada.
Adam FormanDepartment of Chemistry, Faculty of Arts and Sciences, University of Toronto, Toronto, Ontario M5S 3H6, Canada.ORCID 0000-0001-7410-3051
Mark NitzDepartment of Chemistry, Faculty of Arts and Sciences, University of Toronto, Toronto, Ontario M5S 3H6, Canada.ORCID 0000-0001-8078-2265
Jeroen D C CodéeLeiden Institute of Chemistry, Leiden University, 2300RA Leiden, The Netherlands.
Isabel UsónStructural Biology, Instituto de Biología Molecular de Barcelona, CSIC, Carrer Baldiri Reixac 15, 3 A17, Barcelona 08028, Spain.
Donald C SheppardDepartment of Microbiology and Immunology, Faculty of Medicine, McGill University, Montreal, Quebec H3A 2B4, Canada donald.sheppard@mcgill.ca.
P Lynne HowellProgram in Molecular Medicine, The Hospital for Sick Children, Toronto, Ontario M5G 1X8, Canada howell@sickkids.ca.
University of Toronto · CAMcGill University Health Centre · CALeiden University · NLHospital for Sick Children · CAInstitució Catalana de Recerca i Estudis Avançats · ESInstitut de Biologia Molecular de Barcelona · ES

Funding

Life Science and Biomedical technology Research center at NSLS-II LSBRP41GM111244 · NIGMS · BROOKHAVEN SCIENCE ASSOC-BROOKHAVEN LAB · PI MCSWEENEY, SEAN · 2014 to 2018
$16.4M
CIHR 123306CIHR 43998CIHR 81361CIHR 89708CIHR FDN-154327CIHR FDN-159902NIGMS NIH HHS P41 GM111244
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Aspergillus fumigatusBiofilmsCrystallography, X-RayFungal ProteinsFungiGlycoside HydrolasesHexosaminidasesPolysaccharidesVirulenceFungal ProteinsgalactosaminogalactanGlycoside HydrolasesHexosaminidasesPolysaccharidesAspergillusbiofilmcarbohydrate biosynthesiscarbohydrate processingenzyme mechanismexopolysaccharide matrixgalactosaminogalactan (GAG)glycoside hydrolaseglycoside hydrolase 114 (GH114)protein structurevirulence factor

Identifiers

PMID31416836
PMCPMC6746457
OpenAlexW2966901273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.